These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 35221476)

  • 1. Sodium-Glucose Cotransporter 2 Inhibitor Use Associated With Fournier's Gangrene: A Review of Case Reports and Spontaneous Post-Marketing Cases.
    Tran BA; Updike WH; Bullers K; Serag-Bolos E
    Clin Diabetes; 2022 Jan; 40(1):78-86. PubMed ID: 35221476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fournier Gangrene Associated with Sodium-Glucose Cotransporter-2 Inhibitors: A Pharmacovigilance Study with Data from the U.S. FDA Adverse Event Reporting System.
    Hu Y; Bai Z; Tang Y; Liu R; Zhao B; Gong J; Mei D
    J Diabetes Res; 2020; 2020():3695101. PubMed ID: 32695827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Rare but Life-Threatening Case of Fournier's Gangrene Caused by Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitor, Empagliflozin.
    Jahir T; Hossain S; Bagum M; Saidi A; Risal R; Schmidt M
    Cureus; 2022 Sep; 14(9):e29264. PubMed ID: 36262942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacovigilance assessment of the association between Fournier's gangrene and other severe genital adverse events with SGLT-2 inhibitors.
    Fadini GP; Sarangdhar M; De Ponti F; Avogaro A; Raschi E
    BMJ Open Diabetes Res Care; 2019; 7(1):e000725. PubMed ID: 31641524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Case of Fournier's Gangrene in a Patient Taking Canagliflozin for the Treatment of Type II Diabetes Mellitus.
    Elbeddini A; Gallinger J; Davey M; Brassard S; Gazarin M; Plourde F; Aly A
    Am J Case Rep; 2020 Feb; 21():e920115. PubMed ID: 32089542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute renal failure with sodium-glucose-cotransporter-2 inhibitors: Analysis of the FDA adverse event report system database.
    Perlman A; Heyman SN; Matok I; Stokar J; Muszkat M; Szalat A
    Nutr Metab Cardiovasc Dis; 2017 Dec; 27(12):1108-1113. PubMed ID: 29174031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fournier´s Gangrene Under Sodium-Glucose Cotransporter 2 Inhibitor Therapy as a Life-Threatening Adverse Event: A Case Report and Review of the Literature.
    Rodler S; Weig T; Finkenzeller C; Stief C; Staehler M
    Cureus; 2019 Sep; 11(9):e5778. PubMed ID: 31723537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SGLT2 inhibitors associated pancreatitis: signal identification through disproportionality analysis of spontaneous reports and review of case reports.
    Palapra H; Viswam SK; Kalaiselvan V; Undela K
    Int J Clin Pharm; 2022 Dec; 44(6):1425-1433. PubMed ID: 36224513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sodium-glucose cotransporter-2 (SGLT2) inhibitor-induced euglycemic diabetic ketoacidosis complicating the perioperative management of a patient with type 2 diabetes mellitus (T2DM) and Fournier's gangrene: A case report.
    Lindsay PJ; Gibson LE; Bittner EA; Berg S; Chang MG
    Int J Surg Case Rep; 2020; 77():463-466. PubMed ID: 33395826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Case literature analysis of Fournier's gangrene caused by sodium-glucose protein-2 inhibitors.
    Liu H
    Front Med (Lausanne); 2024; 11():1301105. PubMed ID: 38681048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fournier's Gangrene in a Patient with Type 2 Diabetes Mellitus Treated with Empagliflozin: A Case Report.
    Nagano Y; Yakame NK; Aoki H; Yamakawa T; Kondo NI
    Drug Saf Case Rep; 2019 Oct; 6(1):11. PubMed ID: 31628552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fournier's Gangrene as an Adverse Event Following Treatment with Sodium Glucose Cotransporter 2 Inhibitors.
    Suciu IM; Greluș A; Cozlac AR; Suciu BS; Stoica S; Luca S; Luca CT; Gaiță DI
    Medicina (Kaunas); 2024 May; 60(5):. PubMed ID: 38793020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacovigilance of Sodium-Glucose Cotransporter-2 Inhibitors for Genital Fungal Infections and Urinary Tract Infections: A Review of the Food and Drug Administration Adverse Event Reporting System Database.
    Mohammad H; Borja-Hart N
    J Pharm Technol; 2018 Aug; 34(4):144-148. PubMed ID: 34860970
    [No Abstract]   [Full Text] [Related]  

  • 14. Fournier Gangrene Associated With Sodium-Glucose Cotransporter-2 Inhibitors: A Review of Spontaneous Postmarketing Cases.
    Bersoff-Matcha SJ; Chamberlain C; Cao C; Kortepeter C; Chong WH
    Ann Intern Med; 2019 Jun; 170(11):764-769. PubMed ID: 31060053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fournier's gangrene under SGLT-2 inhibitor therapy: A literature review and case report.
    Ellegård L; Prytz M
    Int J Surg Case Rep; 2020; 77():692-694. PubMed ID: 33395875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SGLT2 Inhibitors and the Risk of Hospitalization for Fournier's Gangrene: A Nested Case-Control Study.
    Wang T; Patel SM; Hickman A; Liu X; Jones PL; Gantz I; Koro CE
    Diabetes Ther; 2020 Mar; 11(3):711-723. PubMed ID: 32052281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early Presentation of a Rare Complication of Sodium-Glucose Cotransporter-2 Inhibitors 10 Days After Initiation: Case Report and Literature Review.
    Elshimy G; Correa R; Alsayed M; Jyothinagaram S
    Cureus; 2019 Jul; 11(7):e5173. PubMed ID: 31423402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perspectives From a Regional Plastic Surgery Centre on Evidence for the Purported Link Between SGLT2 Inhibitors and Fournier's Gangrene.
    Taylor L; Asmar O; Mandal A; Tridente A; Hardy K; Shokrollahi K
    Front Surg; 2021; 8():754101. PubMed ID: 34957200
    [No Abstract]   [Full Text] [Related]  

  • 19. Fournier's Gangrene and Diabetic Ketoacidosis Associated with Sodium Glucose Co-Transporter 2 (SGLT2) Inhibitors: Life-Threatening Complications.
    Kasbawala K; Stamatiades GA; Majumdar SK
    Am J Case Rep; 2020 Jun; 21():e921536. PubMed ID: 32483108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Role of Sodium-Glucose Cotransporter-2 Inhibition in Heart Failure with Preserved Ejection Fraction.
    Brust-Sisti L; Rudawsky N; Gonzalez J; Brunetti L
    Pharmacy (Basel); 2022 Nov; 10(6):. PubMed ID: 36548322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.